| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 6 |
| GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4HSE4
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.375 |
| CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.686 |
| CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.628 |
| CLV_PCSK_FUR_1 | 89 | 93 | PF00082 | 0.698 |
| CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.362 |
| CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.641 |
| CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.579 |
| CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.628 |
| CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.703 |
| CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.398 |
| CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.398 |
| CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.607 |
| DOC_CYCLIN_RxL_1 | 67 | 77 | PF00134 | 0.413 |
| DOC_USP7_MATH_1 | 90 | 94 | PF00917 | 0.464 |
| DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.525 |
| LIG_14-3-3_CanoR_1 | 89 | 95 | PF00244 | 0.526 |
| LIG_BRCT_BRCA1_1 | 29 | 33 | PF00533 | 0.480 |
| LIG_FHA_1 | 53 | 59 | PF00498 | 0.509 |
| LIG_FHA_1 | 73 | 79 | PF00498 | 0.488 |
| LIG_FHA_2 | 8 | 14 | PF00498 | 0.583 |
| LIG_LIR_Gen_1 | 61 | 72 | PF02991 | 0.417 |
| LIG_LIR_Nem_3 | 30 | 36 | PF02991 | 0.463 |
| LIG_LIR_Nem_3 | 61 | 67 | PF02991 | 0.424 |
| LIG_SH2_CRK | 46 | 50 | PF00017 | 0.421 |
| LIG_SH2_NCK_1 | 12 | 16 | PF00017 | 0.690 |
| LIG_SH2_SRC | 12 | 15 | PF00017 | 0.600 |
| LIG_SH2_STAP1 | 12 | 16 | PF00017 | 0.587 |
| LIG_SH2_STAP1 | 46 | 50 | PF00017 | 0.424 |
| LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.335 |
| LIG_SH3_3 | 46 | 52 | PF00018 | 0.456 |
| LIG_TRAF2_1 | 11 | 14 | PF00917 | 0.671 |
| LIG_TRAF2_1 | 79 | 82 | PF00917 | 0.420 |
| LIG_TYR_ITIM | 44 | 49 | PF00017 | 0.358 |
| LIG_UBA3_1 | 32 | 39 | PF00899 | 0.327 |
| LIG_WRPW_2 | 6 | 9 | PF00400 | 0.620 |
| MOD_CK2_1 | 53 | 59 | PF00069 | 0.534 |
| MOD_CK2_1 | 7 | 13 | PF00069 | 0.585 |
| MOD_CK2_1 | 76 | 82 | PF00069 | 0.434 |
| MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.733 |
| MOD_GSK3_1 | 72 | 79 | PF00069 | 0.455 |
| MOD_N-GLC_1 | 52 | 57 | PF02516 | 0.698 |
| MOD_NEK2_1 | 18 | 23 | PF00069 | 0.624 |
| MOD_PIKK_1 | 77 | 83 | PF00454 | 0.451 |
| MOD_PK_1 | 45 | 51 | PF00069 | 0.423 |
| MOD_PKA_2 | 90 | 96 | PF00069 | 0.511 |
| MOD_Plk_4 | 27 | 33 | PF00069 | 0.487 |
| MOD_Plk_4 | 45 | 51 | PF00069 | 0.312 |
| MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.525 |
| TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.411 |
| TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.620 |
| TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.404 |
| TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.483 |
| TRG_ER_diArg_1 | 88 | 91 | PF00400 | 0.489 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PBL3 | Leptomonas seymouri | 74% | 100% |
| A0A1X0P0H9 | Trypanosomatidae | 57% | 69% |
| A0A3S7WP03 | Leishmania donovani | 100% | 100% |
| A0A422NDL6 | Trypanosoma rangeli | 47% | 91% |
| A4H469 | Leishmania braziliensis | 89% | 100% |
| D0A4K0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
| E9AKD0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
| Q4QJH8 | Leishmania major | 90% | 100% |
| V5AVY7 | Trypanosoma cruzi | 54% | 100% |